The DOI matches its Crossref record.
Engineering of a Mouse for the in Vivo Profiling of Estrogen Receptor Activity
Open accessAbstract
In addition to their well known control of reproductive functions, estrogens modulate important physiological processes. The identification of compounds with tissue-selective activity will lead to new drugs mimicking the beneficial effects of estrogen on the prevention of osteoporosis and cardiovascular or neurodegenerative diseases, while avoiding its detrimental proliferative effects. As an innovative model for the in vivo identification of new selective estrogen receptor modulators (SERMs), we engineered a mouse genome to express a luciferase reporter gene ubiquitously. The constructs for transgenesis consist of the reporter gene driven by a dimerized estrogen-responsive element (ERE) and a minimal promoter. Insulator sequences, either matrix attachment region (MAR) or β-globin hypersensitive site 4 (HS4), flank the construct to achieve a generalized, hormoneresponsive luciferase expression. In the mouse we generated, the reporter expression is detectable in all 26 tissues examined, but is induced by 17β-estradiol (E2) only in 15 of them, all expressing estrogen receptors (ERs). Immunohistochemical studies show that in the mouse uterus, luciferase and ERs colocalize. In primary cultures of bone marrow cells explanted from the transgenic mice and in vivo, luciferase activity accumulates with increasing E2 concentration. E2 activity is blocked by the ER full antagonist ICI 182,780. Tamoxifen shows partial agonist activity in liver and bone when administered to the animals. In the mouse system here illustrated, by biochemical, immunohistochemical, and pharmacological criteria, luciferase content reflects ER transcriptional activity and thus represents a novel system for the study of ER dynamics during physiological fluctuations of estrogen and for the identification of SERMs or endocrine disruptors. . At the present time, molecules active through estrogen receptors (ERs) are used in fertility control, endocrine dysfunction, and cancer therapy. In postmenopausal women, estrogen replacement therapy (2) was proven efficacious for the prevention of osteoporosis (3), and several lines of study suggested that 17β-estradiol (E2) has beneficial effects in cardiovascular (4, 5) and selected neurodegenerative diseases (6). Unfortunately, the prolonged use of this hormone has been associated with increased risk of breast and uterine cancer (7). The discovery that synthetic ligands of the ER may exhibit tissue-specific agonist or antagonist activity raised a new interest in the use of these compounds for estrogen replacement therapy (8, 9). These selective estrogen receptor modulators or SERMs are identified by comparative screening in cells of different origin to characterize their tissue-specific profile (agonist/antagonist). Generally, the study is carried out in transformed cell lines stably or transiently transfected with ERα or -β and a reporter of the receptor’s activated state. In addition to limiting the analysis to a selected number of cells, this method may also provide erroneous or defective results. In fact, the tissue-specific agonist/antagonist activity of SERMs has been attributed to the presence of cell-specific proteins capable of interacting with the hormone receptor complex (10), and these proteins may be aberrantly expressed in cancer cells (11). Thus, the major shortcoming of this screening procedure is associated with the requirement of further in vivo analysis for the identification of the pharmacodynamic properties of the molecule to be developed. The availability of an engineered mouse carrying an ER reporter expressed ubiquitously as a transgene would represent a remarkable advancement for the identification and profiling of new SERMs. In addition, such a model would be invaluable for the spatio-temporal localization of ER activity and could provide data of major impact for the full comprehension of estrogens and ER functions from development to aging. Such an experimental system can hardly be generated by classical transgenesis because of the difficulty in obtaining a regulated expression of the transgene (12). To overcome this limitation, we made use of insulator sequences previously described to oppose the interference of the host genome on the expression of the ectopic genes (13, 14). In this study we describe a construct that led to ubiquitous and estrogen-regulated expression of a reporter transgene. The transgenic mouse we generated represents an innovative model for the study of the in vivo dynamics of intracellular receptor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 41
- Alves, 1999, Estrogens and antiestrogens., Handbook of Experimental Pharmacology., 135
- Grodstein, 1997, Postmenopausal hormone therapy and mortality., N Engl J Med, 336, 1769, 10.1056/NEJM199706193362501 · DOI · Paper page
- Ettinger, 1999, Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators., JAMA, 282, 637, 10.1001/jama.282.7.637 · DOI · Paper page
- Mendelsohn, 1999, Mechanisms of disease: the protective effects of estrogen on the cardiovascular system., N Engl J Med, 340, 1801, 10.1056/NEJM199906103402306 · DOI · Paper page
- Nathan, 1997, Estrogen and atherosclerosis., Annu Rev Pharmacol Toxicol, 37, 477, 10.1146/annurev.pharmtox.37.1.477 · DOI · Paper page
- Birge, 1997, The role of estrogen in the treatment and prevention of dementia., Am J Med, 103, 1, 10.1016/S0002-9343(97)00263-5 · DOI
- Schairer, 2000, Menopausal estrogen and estrogenprogestin replacement therapy and breast cancer risk., JAMA, 283, 485, 10.1001/jama.283.4.485 · DOI · Paper page
- Fuleihan, 1997, Tissue-specific estrogens–the promise for the future., N Engl J Med, 337, 1686, 10.1056/NEJM199712043372309 · DOI
- Purdie, 1999, The selective oestrogen receptor modulation: evolution and clinical applications., Br J Clin Pharmacol, 48, 785, 10.1046/j.1365-2125.1999.00089.x · doi:10.1046/j.1365-2125.1999.00089.x
- Smith, 1997, Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifene., Mol Endocrinol, 11, 657, 10.1210/mend.11.6.0009 · doi:10.1210/mend.11.6.0009 · Paper page
- Anzick, 1997, AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer., Science, 277, 965, 10.1126/science.277.5328.965 · DOI · Paper page
- Wilson, 1990, Position effects on eukaryotic gene expression., Annu Rev Cell Biol, 6, 679, 10.1146/annurev.cb.06.110190.003335 · DOI · Paper page
- Sun, 1999, Putting boundaries on silence., Cell, 99, 459, 10.1016/S0092-8674(00)81534-2 · DOI
- Bell, 1999, Stopped at the border: boundaries and insulators., Curr Opin Genet Dev, 9, 191, 10.1016/S0959-437X(99)80029-X · DOI · Paper page
- Stief, 1989, A nuclear DNA attachment element mediates elevated and position-independent gene activity., Nature, 341, 343, 10.1038/341343a0 · DOI · Paper page
- Chung, 1993, A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila., Cell, 74, 505, 10.1016/0092-8674(93)80052-G · DOI · Paper page
- Roper, 1999, Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses., Endocrinology, 140, 556, 10.1210/endo.140.2.6521 · DOI
- Spearow, 1999, Genetic variation in susceptibility to endocrine disruption by estrogen in mice., Science, 285, 1259, 10.1126/science.285.5431.1259 · DOI · Paper page
- Couse, 1997, Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse., Endocrinology, 138, 4613, 10.1210/endo.138.11.5496 · DOI · Paper page
- Dinghra, 1999, Antiestrogens—tamoxifen, SERMs and beyond., Invest New Drugs, 17, 285, 10.1023/A:1006348907994 · DOI
- McKenna, 1999, Nuclear receptor coregulators: cellular and molecular biology., Endocr Rev, 20, 321
- Bevan, 1999, The role of coactivators in steroid hormone action., Exp Cell Res, 253, 349, 10.1006/excr.1999.4719 · DOI
- Brzozowski, 1997, Molecular basis of agonism and antagonism in the oestrogen receptor., Nature, 389, 753, 10.1038/39645 · DOI · Paper page
- Shiau, 1998, The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen., Cell, 95, 927, 10.1016/S0092-8674(00)81717-1 · DOI · Paper page
- Darimont, 1998, Structure and specificity of nuclear receptor-coactivator interactions., Genes Dev, 12, 3346, 10.1101/gad.12.21.3343 · DOI · Paper page
- Patrone, 1998, Divergent pathways regulate ligand-independent activation of ERα in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells., Mol Endocrinol, 12, 835
- Power, 1991, Dopaminergic and ligand-independent activation of steroid hormone receptors., Science, 254, 1636, 10.1126/science.1749936 · DOI · Paper page
- Thompson, 1991, Modulation of firefly luciferase stability and impact on studies of gene regulation., Gene, 103, 171, 10.1016/0378-1119(91)90270-L · DOI · Paper page
- Sladek, 1997, The orphan nuclear receptor estrogen-related receptor a is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene., Mol Cell Biol, 17, 5400, 10.1128/MCB.17.9.5400 · DOI · Paper page
- Vanacker, 1999, Transcriptional targets shared by estrogen receptor related receptors (ERRs) and estrogen receptor (ER) α but not by ERβ, EMBO J, 18, 4270, 10.1093/emboj/18.15.4270 · DOI · Paper page
- Heard, 2000, Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue specific isoforms are expressed during development in the adult., Mol Endocrinol, 14, 382
- Solomin, 1998, Retinoid-X receptor signalling in the developing spinal cord, Nature, 395, 398, 10.1038/26515 · DOI
- de Urquiza, 1999, Feedback-inducible nuclear-receptor-driven reporter gene expression in transgenic mice, Proc Natl Acad Sci USA, 96, 13270, 10.1073/pnas.96.23.13270 · DOI
- Mader, 1993, Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors., J Biol Chem, 268, 591, 10.1016/S0021-9258(18)54192-2 · DOI · Paper page
- McKnight, 1982, Transcriptional control signals of a eukaryotic protein-coding gene., Science, 217, 316, 10.1126/science.6283634 · DOI · Paper page
- Luckow, 1987, CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements., Nucleic Acids Res, 15, 5490, 10.1093/nar/15.13.5490 · DOI · Paper page
- Wang, 1997, Ligand-inducible and liver-specific target gene expression in transgenic mice., Nat Biotechnol, 15, 239, 10.1038/nbt0397-239 · DOI · Paper page
- McKnight, 1992, Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice., Proc Natl Acad Sci USA, 89, 6943, 10.1073/pnas.89.15.6943 · DOI · Paper page
- Ma, 1993, Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line., Proc Natl Acad Sci USA, 90, 3740, 10.1073/pnas.90.8.3740 · DOI
- Ciana, 1998, Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo., EMBO J, 17, 7382, 10.1093/emboj/17.24.7382 · DOI
- Bradford, 1976, A rapid and sensitive methods for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding., Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
Cited by
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy
Wilkins, B. J., Dai, Y.-S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., Jones, F., Kimball, T. R., & Molkentin, J. D. (2004) · Circulation Research · doi:10.1161/01.res.0000109415.17511.18 · Cited by 761
Insulators: many functions, many mechanisms
West, A. G., Gaszner, M., & Felsenfeld, G. (2002) · Genes & Development · doi:10.1101/gad.954702 · Cited by 631
Protective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 522
Recillas-Targa, F., Pikaart, M. J., Burgess-Beusse, B., Bell, A. C., Litt, M. D., West, A. G., Gaszner, M., & Felsenfeld, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102179399 · Cited by 382
27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator
DuSell, C. D., Umetani, M., Shaul, P. W., Mangelsdorf, D. J., & McDonnell, D. P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0383 · Cited by 301
Metadata
- Authors
- Ciana, P.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2001-07-01
- Volume
- 15
- Issue
- 7
- Pages
- 1104-1113
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2082532013
- Cited by
- 182
- References
- 0
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Engineering of a Mouse for the in Vivo Profiling of Estrogen Receptor Activity. https://app.cochat.ai/papers/10.1210/me.15.7.1104
- The paper
- Ciana, P. (2001). Engineering of a Mouse for the in Vivo Profiling of Estrogen Receptor Activity. Molecular Endocrinology. https://doi.org/10.1210/me.15.7.1104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.